R.A. Seaton

5.9k total citations
119 papers, 3.0k citations indexed

About

R.A. Seaton is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, R.A. Seaton has authored 119 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 43 papers in Infectious Diseases and 40 papers in Pharmacology. Recurrent topics in R.A. Seaton's work include Antibiotics Pharmacokinetics and Efficacy (38 papers), Antibiotic Use and Resistance (36 papers) and Antimicrobial Resistance in Staphylococcus (22 papers). R.A. Seaton is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (38 papers), Antibiotic Use and Resistance (36 papers) and Antimicrobial Resistance in Staphylococcus (22 papers). R.A. Seaton collaborates with scholars based in United Kingdom, South Africa and Papua New Guinea. R.A. Seaton's co-authors include David Barr, Mark Gilchrist, Dilip Nathwani, Brian Godman, Jacqueline Sneddon, Amanj Kurdi, S Naraqi, David A. Warrell, Lesley Cooper and Ray Fox and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and BMJ.

In The Last Decade

R.A. Seaton

112 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
R.A. Seaton	1.2k	1.1k	1.1k	1.0k	451	119	3.0k
Alan D. Tice	995 0.9×	1.1k 0.9×	579 0.5×	917 0.9×	651 1.4×	92	3.0k
Jason G. Newland	987 0.9×	454 0.4×	737 0.7×	615 0.6×	369 0.8×	138	2.8k
Susan J. Rehm	737 0.6×	792 0.7×	456 0.4×	841 0.8×	974 2.2×	80	2.8k
Francisco Álvarez-Lerma	2.5k 2.2×	832 0.7×	911 0.9×	1.8k 1.7×	262 0.6×	201	5.0k
Håkan Hanberger	1.3k 1.1×	741 0.7×	1.2k 1.1×	716 0.7×	250 0.6×	106	4.0k
Maureen Bolon	842 0.7×	527 0.5×	560 0.5×	706 0.7×	2.0k 4.4×	49	4.0k
J. E. McGowan	1.5k 1.3×	383 0.3×	803 0.8×	1.3k 1.2×	715 1.6×	66	4.1k
Nabin K. Shrestha	1.7k 1.5×	535 0.5×	323 0.3×	1.3k 1.2×	706 1.6×	132	3.1k
Lindsey M. Weiner	996 0.9×	283 0.3×	705 0.7×	822 0.8×	215 0.5×	23	3.1k
Diamantis Plachouras	1.5k 1.3×	866 0.8×	828 0.8×	875 0.8×	241 0.5×	67	3.6k

Countries citing papers authored by R.A. Seaton

Since Specialization

Citations

This map shows the geographic impact of R.A. Seaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.A. Seaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.A. Seaton more than expected).

Fields of papers citing papers by R.A. Seaton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.A. Seaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.A. Seaton. The network helps show where R.A. Seaton may publish in the future.

Co-authorship network of co-authors of R.A. Seaton

This figure shows the co-authorship network connecting the top 25 collaborators of R.A. Seaton. A scholar is included among the top collaborators of R.A. Seaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.A. Seaton. R.A. Seaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Law, Sabrina, et al.. (2025). Successful outpatient parenteral antimicrobial therapy with rezafungin for chronic pulmonary aspergillosis: a case report and health economic assessment. JAC-Antimicrobial Resistance. 7(6). dlaf234–dlaf234.

Roberts, Jason A., Luis Eduardo López-Cortés, James Pollard, et al.. (2025). Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey. JAC-Antimicrobial Resistance. 7(3). dlaf075–dlaf075. 2 indexed citations

Silcock, Jennifer, et al.. (2025). The Greater Bilby ( Macrotis lagotis ) in Queensland, Australia: Distribution, Trends, and Threats. Austral Ecology. 50(4).

Mustafa, Zia Ul, Muhammad Salman, Tauqeer Hussain Mallhi, et al.. (2024). Predictors and outcomes of patients with COVID-19 admitted to intensive care units in Pakistan and the development of nosocomial fungal infections: Findings and implications. IJID Regions. 13. 100445–100445. 1 indexed citations

Bou-Antoun, Sabine, Alistair Leanord, R.A. Seaton, et al.. (2024). Adaptation of the WHO AWaRe (Access, Watch, Reserve) antibiotic classification to support national antimicrobial stewardship priorities in the UK: findings from a modified Delphi approach to achieve expert consensus. JAC-Antimicrobial Resistance. 7(1). dlae218–dlae218. 3 indexed citations

Roberts, Jason A., Steven C. Wallis, C Jamieson, et al.. (2024). Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-Antimicrobial Resistance. 6(2). dlae056–dlae056. 3 indexed citations

Roberts, Jason A., et al.. (2024). A review of antimicrobial stability testing guidance for outpatient parenteral antimicrobial therapy programmes: is it time for global harmonization of testing frameworks?. JAC-Antimicrobial Resistance. 6(6). dlae186–dlae186.

Ness, Valerie, et al.. (2024). The impact of the COVID-19 pandemic on the antimicrobial stewardship workforce in Scottish acute care hospitals—a qualitative study. JAC-Antimicrobial Resistance. 6(6). dlae199–dlae199. 2 indexed citations

Kurdi, Amanj, et al.. (2023). Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis. Expert Review of Anti-infective Therapy. 21(4). 455–475. 2 indexed citations

10.

Acolatse, Joseph Elikem Efui, Robert Incoom, R.A. Seaton, et al.. (2023). Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana. Expert Review of Anti-infective Therapy. 21(12). 1373–1382. 6 indexed citations

11.

Marwick, Charis, Jacqueline Sneddon, Kimberley Kavanagh, et al.. (2022). Feedback of Antibiotic Prescribing in Primary Care (FAPPC) trial: results of a real-world cluster randomized controlled trial in Scotland, UK. Journal of Antimicrobial Chemotherapy. 77(12). 3291–3300. 2 indexed citations

12.

Seaton, R.A., et al.. (2022). Hospital Specialist Palliative Care Team Influence on End-of-Life Care in Coronavirus Disease 2019? A Retrospective Observational Cohort Study. SHILAP Revista de lepidopterología. 3(1). 235–243.

13.

Saïdani, Nadia, Mark Gilchrist, R.A. Seaton, et al.. (2022). Survey of delivery of parenteral antimicrobials in non-inpatient settings across Europe. International Journal of Antimicrobial Agents. 59(4). 106559–106559. 12 indexed citations

14.

Dimitrova, Maria, Mark Gilchrist, & R.A. Seaton. (2021). Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses. BMJ Open. 11(9). e049733–e049733. 45 indexed citations

15.

Browne, Chantelle, N. Muszbek, Ruth Chapman, et al.. (2016). Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin. International Journal of Antimicrobial Agents. 47(5). 357–361. 10 indexed citations

16.

Seaton, R.A., Francesco Menichetti, George Ν. Dalekos, et al.. (2015). Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin® Outcomes Registry and Experience. Advances in Therapy. 32(12). 1192–1205. 55 indexed citations

17.

Chaudhuri, Abhijit, Peter G. E. Kennedy, R.A. Seaton, et al.. (2008). EFNS guideline on the management of community‐acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. European Journal of Neurology. 15(7). 649–659. 161 indexed citations

18.

White, HD, et al.. (2007). One-year outcome following outpatient parenteral antibiotic therapy (OPAT) treated bone and joint infections. Journal of Infection. 55(3). e79–e80. 1 indexed citations

19.

Seaton, R.A., et al.. (1996). Symptomatic Human Immunodeficiency Virus (HIV) infection in Papua New Guinea. Australian and New Zealand Journal of Medicine. 26(6). 783–788. 11 indexed citations

20.

Seaton, R.A., Andrew J. Hamilton, Roderick J. Hay, & David A. Warrell. (1996). Exposure to Cryptococcus neoformans var. gattii — a seroepidemiological study. Transactions of the Royal Society of Tropical Medicine and Hygiene. 90(5). 508–512. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact